Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
19 avr. 2021 06h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., April 19, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the...
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes
16 mars 2021 09h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that on March 15, 2021 it issued an additional $30.0 million aggregate principal...
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors
15 mars 2021 08h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that it will participate in the 2022 Medicare Part D Senior Savings Model, which is...
MannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference
10 mars 2021 17h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference
02 mars 2021 17h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering
02 mars 2021 06h30 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the pricing of $200.0 million aggregate principal amount of 2.50% Convertible Senior...
MannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes
01 mars 2021 07h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it intends to offer, subject to market conditions and other factors, $150.0...
MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results
25 févr. 2021 08h00 HE
|
MannKind
Conference Call to Begin Today at 9:00 AM ET 4Q 2020 Afrezza Net Revenue of $10.1 million; +30% vs. 4Q 2019 • Sequential Quarter Growth +38% vs. 3Q 20202020 Total Revenues of $65.1 million •...
MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
18 févr. 2021 17h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannKind Corporation to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021
18 févr. 2021 09h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 fourth quarter and full year financial results and its management will host a...